Identification of TP53 mutation-associated prognostic genes and investigation of the immune cell infiltration in patients with hepatocellular carcinoma

被引：0
|
作者：
Yang, Qijun [1 ]
Gao, Lianke [3 ]
Xu, Yuhan [2 ]
Cao, Gaoquan [4 ]
He, Yingcheng
Zhang, Wenyige [2 ]
Zhang, Xue [2 ]
Wu, Chengfeng [5 ]
Liao, Kaili [1 ]
Wang, Xiaozhong [1 ]
机构：
[1] Nanchang Univ, Affiliated Hosp 2, Dept Clin Lab, Nanchang 330006, Jiangxi, Peoples R China
[2] Nanchang Univ, Queen Mary Coll, Nanchang 330031, Jiangxi, Peoples R China
[3] Nanchang Univ, Adv Mfg Coll, Nanchang 330031, Jiangxi, Peoples R China
[4] Nanchang Univ, Clin Sch 4, South Rd Bayi Sq, Nanchang 330031, Jiangxi, Peoples R China
[5] Nanchang Univ, Affiliated Hosp 2, Dept Vasc Surg, Nanchang 330006, Jiangxi, Peoples R China
来源：
GENES & DISEASES | 2024年 / 11卷 / 02期
基金：
中国国家自然科学基金;
关键词：
D O I：
10.1016/j.gendis.2023.03.020
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
[No abstract available]
引用
收藏
页码：520 / 523
页数：4
相关论文
共 50 条
  • [31] Clinical and prognostic values of TP53 mutation in patients with acute myeloid leukemia
    张莹
    China Medical Abstracts(Internal Medicine), 2020, 37 (01) : 59 - 59
  • [32] Type of TP53 mutation is not prognostic in high grade serous ovarian carcinoma, but presence is prognostic in endometriosis-associated carcinomas
    Brett, Mary Anne
    Ramus, Susan
    Brenton, James
    Kobel, Martin
    LABORATORY INVESTIGATION, 2019, 99
  • [33] Type of TP53 mutation is not prognostic in high grade serous ovarian carcinoma, but presence is prognostic in endometriosis-associated carcinomas
    Brett, Mary Anne
    Ramus, Susan
    Brenton, James
    Kobel, Martin
    MODERN PATHOLOGY, 2019, 32
  • [34] CENPO is Associated with Immune Cell Infiltration and is a Potential Diagnostic and Prognostic Marker for Hepatocellular Carcinoma
    He, Kun
    Xie, Mengyi
    Li, Jingdong
    He, Yi
    Yin, Yaolin
    INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2022, 15 : 7493 - 7510
  • [35] FGFR4 polymorphism, TP53 mutation, and their combinations are prognostic factors for oral squamous cell carcinoma
    Tanuma, Jun-Ichi
    Izumo, Toshiyuki
    Hirano, Masato
    Oyazato, Yoshitaka
    Hori, Fumiya
    Umemura, Eri
    Shisa, Hayase
    Hiai, Hiroshi
    Kitano, Motoo
    ONCOLOGY REPORTS, 2010, 23 (03) : 739 - 744
  • [36] A Truncated Mutation of TP53 Promotes Chemoresistance in Tongue Squamous Cell Carcinoma
    Du, Xiaoyun
    Zheng, Junheng
    Lu, Xiangwan
    Zhang, Yan
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2025, 26 (05)
  • [37] Mutation analysis of P73 and TP53 in Merkel cell carcinoma
    Van Gele, M
    Kaghad, M
    Leonard, JH
    Van Roy, N
    Naeyaert, JM
    Geerts, ML
    Van Belle, S
    Cocquyt, V
    Bridge, J
    Sciot, R
    De Wolf-Peeters, C
    De Paepe, A
    Caput, D
    Speleman, F
    BRITISH JOURNAL OF CANCER, 2000, 82 (04) : 823 - 826
  • [38] Mutation analysis of P73 and TP53 in Merkel cell carcinoma
    Van Gele M.
    Kaghad M.
    Leonard J.H.
    Van Roy N.
    Naeyaert J.M.
    Geerts M.L.
    Van Belle S.
    Cocquyt V.
    Bridge J.
    Sciot R.
    De Wolf-Peeters C.
    De Paepe A.
    Caput D.
    Speleman F.
    British Journal of Cancer, 2000, 82 (4) : 823 - 826
  • [39] PROGNOSTIC AND THERAPEUTIC ROLE OF TP53 MUTATIONS IN MEDULLOBLASTOMA SUBGROUPS; THERAPEUTIC ROLE OF LITHIUM IN ABROGATION OF TP53 MUTATION ASSOCIATED RADIATION RESISTANCE
    Zhukova, Nataliya
    Martin, Dianna
    Lipman, Tatiana
    Castelo-Branco, Pedro
    Zhang, Cindy
    Fraser, Michael
    Baskin, Berivan
    Ray, Peter
    Bouffet, Eric
    Alman, Benjamin
    Ramaswamy, Vijay
    Dirks, Peter
    Clifford, Steven
    Rutkowski, Stefan
    Pfister, Stefan
    Taylor, Michael
    Malkin, David
    Hawkins, Cynthia
    Tabori, Uri
    PEDIATRIC BLOOD & CANCER, 2012, 59 (06) : 992 - 992
  • [40] Prognostic Value of TP53 Mutation for Transcatheter Arterial Chemoembolization Failure/Refractoriness in HBV-Related Advanced Hepatocellular Carcinoma
    Xue, Miao
    Wu, Yanqin
    Fan, Wenzhe
    Guo, Jian
    Wei, Jialiang
    Wang, Hongyu
    Tan, Jizhou
    Wang, Yu
    Yao, Wang
    Zhao, Yue
    Li, Jiaping
    CANCER RESEARCH AND TREATMENT, 2020, 52 (03): : 925 - 937
12345